MicroRNA-23a 通过靶向 MARK1 促进结直肠癌细胞迁移和增殖。

MicroRNA-23a promotes colorectal cancer cell migration and proliferation by targeting at MARK1.

机构信息

The Second Xiangya Hospital, Central South University, Changsha, China.

Clinical Medical College, Yangzhou University, Yangzhou, China.

出版信息

Acta Biochim Biophys Sin (Shanghai). 2019 Jul 10;51(7):661-668. doi: 10.1093/abbs/gmz047.

Abstract

The functional role of microRNA-23a in tumorigenesis has been investigated; however, the exact mechanism of microRNA-23a (miR-23a) in colorectal cancer development has not been fully explored. In the present study, we aimed to investigate the molecular functional role of miR-23a in colorectal carcinogenesis. Quantitative real-time polymerase chain reaction was conducted to investigate the expression level of miR-23a in tissue samples and cell lines (HCT116 and SW480). CCK-8, colony formation and Transwell assay were used to explore the role of miR-23a in cell proliferation and migration. Dual luciferase reporter assay was used to identify the direct binding of miR-23a with its target, MARK1. Western blot analysis was used to analyze the expression level of MARK1, as well as a confirmed miR-23a target gene, MTSS1, in miR-23a-mimic and miR-23a-inhibit groups. Rescue experiments were conducted by overexpression of MARK1 in miR-23a-mimic-transfected cell lines. The results showed that miR-23a was highly expressed in colorectal cancer tissue and cell lines. MiR-23a could promote proliferation and migration of colorectal cancer cell lines. MARK1 was a direct target of miR-23a and the expression level of MARK1 was down-regulated in miR-23a-mimic-transfected cell lines but up-regulated in miR-23a-inhibit-transfected cells. Overexpression of MARK1 could partly reverse the cancer-promoting function of miR-23a. Our results suggested that miR-23a promotes colorectal cancer cell proliferation and migration by mediating the expression of MARK1. MiR-23a may be a potential therapeutic target for colorectal cancer treatment.

摘要

microRNA-23a 在肿瘤发生中的功能作用已经得到了研究;然而,microRNA-23a(miR-23a)在结直肠癌发展中的确切机制尚未完全探索。在本研究中,我们旨在研究 miR-23a 在结直肠癌细胞发生中的分子功能作用。采用实时定量聚合酶链反应检测组织样本和细胞系(HCT116 和 SW480)中 miR-23a 的表达水平。CCK-8、集落形成和 Transwell 测定用于探索 miR-23a 在细胞增殖和迁移中的作用。双荧光素酶报告基因检测用于鉴定 miR-23a 与其靶基因 MARK1 之间的直接结合。Western blot 分析用于分析 miR-23a 模拟物和 miR-23a 抑制剂组中 MARK1 以及已确认的 miR-23a 靶基因 MTSS1 的表达水平。通过在 miR-23a 模拟物转染的细胞系中转染 MARK1 的过表达进行挽救实验。结果表明,miR-23a 在结直肠癌组织和细胞系中高表达。miR-23a 可促进结直肠癌细胞系的增殖和迁移。MARK1 是 miR-23a 的直接靶基因,在 miR-23a 模拟物转染的细胞系中 MARK1 的表达水平下调,而在 miR-23a 抑制剂转染的细胞中上调。MARK1 的过表达可部分逆转 miR-23a 的促癌功能。我们的结果表明,miR-23a 通过调节 MARK1 的表达促进结直肠癌细胞的增殖和迁移。miR-23a 可能是结直肠癌治疗的潜在治疗靶点。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索